25803136|t|Adjunctive Valproic Acid in Management-Refractory Hyperactive Delirium: A Case Series and Rationale.
25803136|a|Patients with delirium may fail to respond to standard therapies. Sixteen patients with management-refractory hyperactive delirium responded to adjunctive valproic acid, with complete resolution of hyperactive delirium in 13 cases. A rationale for using valproic acid in such circumstances is discussed. 
25803136	11	24	Valproic Acid	Chemical	MESH:D014635
25803136	50	70	Hyperactive Delirium	Disease	MESH:D003693
25803136	101	109	Patients	Species	9606
25803136	115	123	delirium	Disease	MESH:D003693
25803136	175	183	patients	Species	9606
25803136	211	231	hyperactive delirium	Disease	MESH:D003693
25803136	256	269	valproic acid	Chemical	MESH:D014635
25803136	299	319	hyperactive delirium	Disease	MESH:D003693
25803136	355	368	valproic acid	Chemical	MESH:D014635
25803136	Negative_Correlation	MESH:D014635	MESH:D003693

